Harbour BioMed Secures China’s NMPA Approval for Batoclimab, Expanding Treatment Options for Myasthenia Gravis ...
Through its collaboration with OASES and partners across the healthcare ecosystem, Johnson & Johnson looks forward to: ...
Coreline Soft has received U.S. Food and Drug Administration (FDA) 510 (k) clearance for AVIEW Aorta Metrics, its AI-powered ...
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, shared the first data from a ...
GIM-621 is a preclinical-stage first-in-class oral small molecule immunotherapy with potential application across multiple ...
Lunit Inc. (KRX: 328130) and Summit Therapeutics Inc. announced a research agreement to evaluate the use of Lunit SCOPE IO, ...
Nine markets, six questions, one page to pin above the desk. From Japan's 50,000-patient line to China's brand-new seven-year exclusivity, this is what a rare disease developer actually gets across ...
Tairex, an AI healthcare technology company incubated by the Institute for AI Industry Research (AIR) at Tsinghua University, ...
Therakos Development Limited, a global pioneer in immunomodulatory therapy delivered at the bedside through extracorporeal ...
The new fiscal year is already two days into its own ledger. On 2 October 2026, FDA issued a letter to Hanlim Pharm in Yongin ...
New CAS Connections integration combines over 150 years of curated scientific knowledge with CAS Newton’s agentic AI ...
UK Collaboration to Explore Digital-First Screening for Early Detection of High Blood Pressure, Expanding Preventive ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results